News Chart CervoMed Inc.

Equities

CRVO

US15713L1098

Real-time Estimate Cboe BZX Other stock markets 12:06:43 21/06/2024 am IST			5-day change	1st Jan Change
20.82 ^USD	+7.13%		+5.26%	+172.61%

11/06	CervoMed Inc. Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies	CI
29/05	JonesTrading Starts CervoMed With Buy Rating, $70 Price Target	MT

9097cf9e9aa6c894d942.k1H19kyZwZmmp3fPSvl4ov0i_INs4p_B4mTu8qqpiGU.0AuxjzargPTN1T6dGJ8x5pFzqO1ah62xgwuMv5n_yjLgZp6DNcOq48jzFA~9b07b1d49f9ac68ed6205c1fd3276f57